NS

Neetu Singh

Active Director Director DIN 07730635
DIN 07730635 First appointment Mar 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Neetu Singh

Data last updated:

Neetu Singh is a Director at Genesis Medipharma Private Limited (since 2017). The company operates in Chemicals. Genesis Medipharma Private Limited reported revenue of ₹10,870 (FY 2025).

DIN 07730635
Primary Designation Director
Industry Chemicals
First Appointment 02 Mar 2017
Oldest Company Age 20 yrs
Largest company Genesis Medipharma Private Limited · ₹10,870 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genesis Medipharma Private Limited U24232UP2006PTC031555
Director02 Mar 20172006₹10,870 (FY 2025)Active

Board colleagues of Neetu Singh

NameDINCompanyDesignation
Shiv Mohan Awasthi01597416Genesis Medipharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Genesis Medipharma Private Limited
Premium access

Shareholding and investment profile for Neetu Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neetu Singh

Neetu Singh currently holds 1 directorship: Genesis Medipharma Private Limited (Director, since 02 Mar 2017, revenue ₹10,870 (FY 2025)).

Neetu Singh was first appointed on 02 Mar 2017 as Director at Genesis Medipharma Private Limited.

The current boards of Neetu Singh's companies include Shiv Mohan Awasthi (Genesis Medipharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available